statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Buy Rating Affirmed for Profound Medical on Reimbursement and Market Expansion Prospects

In a report released today, Rick Wise from Stifel Nicolaus upgraded Profound Medical (PRN Research Report) to a Buy, with a price target of $12.0...

Profound Medical (PROF, $8.27) entered Downtrend as Momentum indicator drops below 0 level on Apr 01, 2024

This indicator may be signaling that PROF's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

Profound Medical (PROF, $8.27) price exceeded its 50-day Moving Average on April 01, 2024

This price move could indicate a change in the trend, and may be a sell signal for investors...

Profound Medical (NASDAQ:PROF) and Minerva Surgical (NASDAQ:UTRS) Head to Head Survey

Profound Medical (NASDAQ:PROF - Get Free Report) and Minerva Surgical (NASDAQ:UTRS - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the...

Profound Medical (PROF, $8.53) Moving Average Convergence Divergence (MACD) Histogram turned positive on March 28, 2024

This is a Bullish indicator signaling PROF's price could rise from here. Traders may explore going long the stock or buying call options...

Profound Medical (PROF, $8.28) Stochastic Oscillator left the oversold zone on March 27, 2024

This is a signal that PROF's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...

Profound Medical (PROF, $8.15) entered Downtrend as Momentum indicator drops below 0 level on Mar 26, 2024

Profound Medical (PROF, $8.13) price exceeded its 50-day Moving Average on March 18, 2024

Profound Medical price target lowered by $1.95 at Alliance Global Partners, here's why

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Profound Medical (PROF, $8) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 8, 2024

This is a Bearish indicator signaling PROF's price could decline from here. Traders may explore shorting the stock or put options...

Profound Medical Corp. engages in developing, manufacturing, and marketing of therapeutic platforms that combine real-time magnetic resonance imaging with directional and focused ultrasound technology for incision-free ablation of diseased tissue. Its platforms offer clinicians and patients incision-free alternatives to current standards of care, which could include traditional surgery or radiation therapy. Its products include TULSA-PRO and Sonalleve. The company was founded in 2008 and is headquartered in Mississauga, Canada.

Volume	37,054.00
52-Wk High	$12.37
52-Wk Low	$7.11

Current Price	$11.18
Prev Close	$10.89
Open	$10.99
Dividend Yield	0.00%
50-Day Moving Average	$8.70
Beta	1.19
Avg. Volume	25,930.84
PE Ratio	-8.50

52-Week High	$12.37
52-Week Low	$7.11
Market Capitalization	$266.03M
EPS	-$1.28
Price to Book	5.80
Revenue Per Employee	$55,335.88
Enterprise Value/EBITDA	-6.09

PROF Profound Medical Corp

About

Feed

News

Earnings

Fundamentals